🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Austria / NCT03267615
Recruiting Observational

VICIS - Vienna Cirrhosis Study

NCT03267615 · tracked via the Priya Life Science Austria tracker
Phase
Observational
Started
2017-02-01
Last updated
2025-09-25

Condition(s) studied

Liver CirrhosisPortal HypertensionAscitesVariceal HemorrhageHepatic Encephalopathy

Study summary

Patients with advanced chronic liver diseases treated at the Vienna General Hospital of the Medical University of Vienna will be offered to participate in this prospective observational trial - including an optional participation in a biobank.

Clinical parameters and laboratory parameters will be recorded for all patients and patients will undergo a regular follow-up schedule with clinical visits at the Vienna General Hospital.

This study is linked to a biobank with serum/plasma, ascitic fluid, urine, GI tract mucosal biopsies, liver biopsies and stool collected from the study participants.

Eligibility

Sex
ALL
Min age
18 Years
Max age
100 Years
Healthy volunteers
No
Inclusion Criteria: * Age \>18 years and \<100 years * Diagnosis of advanced chronic liver disease (by liver stiffness ≥10kPa, HVPG\>5mmHg or Histology F3/F4) * Written informed consent Exclusion Criteria: * Withdrawal of written informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Medical University of Vienna Vienna Austria Recruiting

More Medical University of Vienna trials in Austria

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03267615 on ClinicalTrials.gov ↗ ← All trials in Austria